APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tolbutamide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tolbutamide Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchTolbutamide Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Tolbutamide Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Tolbutamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tolbutamide Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Tolbutamide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Tolbutamide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tolbutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tolbutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tolbutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tolbutamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tolbutamide include SINE, Mylan, Changjiang Pharma, Pengyao Pharma, EASHU Pharma, Changzhou Pharma, Vexxa LifeScience, Sovereign and Genesis Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tolbutamide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tolbutamide, also provides the sales of main regions and countries. Of the upcoming market potential for Tolbutamide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tolbutamide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tolbutamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tolbutamide sales, projected growth trends, production technology, application and end-user industry.

Tolbutamide Segment by Company

SINE

Mylan

Changjiang Pharma

Pengyao Pharma

EASHU Pharma

Changzhou Pharma

Vexxa LifeScience

Sovereign

Genesis Pharma

Tolbutamide Segment by Type

Oral

Injection

Tolbutamide Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Tolbutamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tolbutamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tolbutamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tolbutamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tolbutamide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tolbutamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tolbutamide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tolbutamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Tolbutamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacies Major Manufacturers Table 6. Online Pharmacies Major Manufacturers Table 7. Hospital Pharmacies Major Manufacturers Table 8. Tolbutamide Industry Trends Table 9. Tolbutamide Industry Drivers Table 10. Tolbutamide Industry Opportunities and Challenges Table 11. Tolbutamide Industry Restraints Table 12. Global Tolbutamide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Tolbutamide Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Tolbutamide Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Tolbutamide Revenue Market Share by Region (2021-2026) Table 16. Global Tolbutamide Revenue Market Share by Region (2027-2032) Table 17. Global Tolbutamide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 18. Global Tolbutamide Sales by Region (2021-2026) & (kg) Table 19. Global Tolbutamide Sales by Region (2027-2032) & (kg) Table 20. Global Tolbutamide Sales Market Share by Region (2021-2026) Table 21. Global Tolbutamide Sales Market Share by Region (2027-2032) Table 22. Global Tolbutamide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Tolbutamide Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Tolbutamide Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Tolbutamide Sales Market Share by Manufacturers (2021-2026) Table 26. Global Tolbutamide Sales Price (US$/kg) of Manufacturers (2021-2026) Table 27. Global Tolbutamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Tolbutamide Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Tolbutamide Manufacturers, Product Type & Application Table 30. Global Tolbutamide Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Tolbutamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Tolbutamide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Tolbutamide Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Tolbutamide Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Tolbutamide Revenue Market Share by Type (2021-2026) Table 37. Global Tolbutamide Revenue Market Share by Type (2027-2032) Table 38. Global Tolbutamide Sales by Type 2021 VS 2025 VS 2032 (kg) Table 39. Global Tolbutamide Sales by Type (2021-2026) & (kg) Table 40. Global Tolbutamide Sales by Type (2027-2032) & (kg) Table 41. Global Tolbutamide Sales Market Share by Type (2021-2026) Table 42. Global Tolbutamide Sales Market Share by Type (2027-2032) Table 43. Global Tolbutamide Price by Type (2021-2026) & (US$/kg) Table 44. Global Tolbutamide Price by Type (2027-2032) & (US$/kg) Table 45. Global Tolbutamide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Tolbutamide Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Tolbutamide Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Tolbutamide Revenue Market Share by Application (2021-2026) Table 49. Global Tolbutamide Revenue Market Share by Application (2027-2032) Table 50. Global Tolbutamide Sales by Application 2021 VS 2025 VS 2032 (kg) Table 51. Global Tolbutamide Sales by Application (2021-2026) & (kg) Table 52. Global Tolbutamide Sales by Application (2027-2032) & (kg) Table 53. Global Tolbutamide Sales Market Share by Application (2021-2026) Table 54. Global Tolbutamide Sales Market Share by Application (2027-2032) Table 55. Global Tolbutamide Price by Application (2021-2026) & (US$/kg) Table 56. Global Tolbutamide Price by Application (2027-2032) & (US$/kg) Table 57. SINE Company Information Table 58. SINE Business Overview Table 59. SINE Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 60. SINE Tolbutamide Product Portfolio Table 61. SINE Recent Development Table 62. Mylan Company Information Table 63. Mylan Business Overview Table 64. Mylan Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 65. Mylan Tolbutamide Product Portfolio Table 66. Mylan Recent Development Table 67. Changjiang Pharma Company Information Table 68. Changjiang Pharma Business Overview Table 69. Changjiang Pharma Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. Changjiang Pharma Tolbutamide Product Portfolio Table 71. Changjiang Pharma Recent Development Table 72. Pengyao Pharma Company Information Table 73. Pengyao Pharma Business Overview Table 74. Pengyao Pharma Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Pengyao Pharma Tolbutamide Product Portfolio Table 76. Pengyao Pharma Recent Development Table 77. EASHU Pharma Company Information Table 78. EASHU Pharma Business Overview Table 79. EASHU Pharma Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. EASHU Pharma Tolbutamide Product Portfolio Table 81. EASHU Pharma Recent Development Table 82. Changzhou Pharma Company Information Table 83. Changzhou Pharma Business Overview Table 84. Changzhou Pharma Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Changzhou Pharma Tolbutamide Product Portfolio Table 86. Changzhou Pharma Recent Development Table 87. Vexxa LifeScience Company Information Table 88. Vexxa LifeScience Business Overview Table 89. Vexxa LifeScience Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Vexxa LifeScience Tolbutamide Product Portfolio Table 91. Vexxa LifeScience Recent Development Table 92. Sovereign Company Information Table 93. Sovereign Business Overview Table 94. Sovereign Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Sovereign Tolbutamide Product Portfolio Table 96. Sovereign Recent Development Table 97. Genesis Pharma Company Information Table 98. Genesis Pharma Business Overview Table 99. Genesis Pharma Tolbutamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. Genesis Pharma Tolbutamide Product Portfolio Table 101. Genesis Pharma Recent Development Table 102. North America Tolbutamide Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Tolbutamide Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Tolbutamide Sales by Type (2021-2026) & (kg) Table 105. North America Tolbutamide Sales by Type (2027-2032) & (kg) Table 106. North America Tolbutamide Sales Price by Type (2021-2026) & (US$/kg) Table 107. North America Tolbutamide Sales Price by Type (2027-2032) & (US$/kg) Table 108. North America Tolbutamide Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Tolbutamide Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Tolbutamide Sales by Application (2021-2026) & (kg) Table 111. North America Tolbutamide Sales by Application (2027-2032) & (kg) Table 112. North America Tolbutamide Sales Price by Application (2021-2026) & (US$/kg) Table 113. North America Tolbutamide Sales Price by Application (2027-2032) & (US$/kg) Table 114. North America Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Tolbutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Tolbutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Tolbutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 118. North America Tolbutamide Sales by Country (2021-2026) & (kg) Table 119. North America Tolbutamide Sales by Country (2027-2032) & (kg) Table 120. North America Tolbutamide Sales Price by Country (2021-2026) & (US$/kg) Table 121. North America Tolbutamide Sales Price by Country (2027-2032) & (US$/kg) Table 122. United States Tolbutamide Revenue (2021-2032) & (US$ Million) Table 123. Canada Tolbutamide Revenue (2021-2032) & (US$ Million) Table 124. Mexico Tolbutamide Revenue (2021-2032) & (US$ Million) Table 125. Europe Tolbutamide Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Tolbutamide Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Tolbutamide Sales by Type (2021-2026) & (kg) Table 128. Europe Tolbutamide Sales by Type (2027-2032) & (kg) Table 129. Europe Tolbutamide Sales Price by Type (2021-2026) & (US$/kg) Table 130. Europe Tolbutamide Sales Price by Type (2027-2032) & (US$/kg) Table 131. Europe Tolbutamide Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Tolbutamide Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Tolbutamide Sales by Application (2021-2026) & (kg) Table 134. Europe Tolbutamide Sales by Application (2027-2032) & (kg) Table 135. Europe Tolbutamide Sales Price by Application (2021-2026) & (US$/kg) Table 136. Europe Tolbutamide Sales Price by Application (2027-2032) & (US$/kg) Table 137. Europe Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Tolbutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe Tolbutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe Tolbutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 141. Europe Tolbutamide Sales by Country (2021-2026) & (kg) Table 142. Europe Tolbutamide Sales by Country (2027-2032) & (kg) Table 143. Europe Tolbutamide Sales Price by Country (2021-2026) & (US$/kg) Table 144. Europe Tolbutamide Sales Price by Country (2027-2032) & (US$/kg) Table 145. Germany Tolbutamide Revenue (2021-2032) & (US$ Million) Table 146. France Tolbutamide Revenue (2021-2032) & (US$ Million) Table 147. U.K. Tolbutamide Revenue (2021-2032) & (US$ Million) Table 148. Italy Tolbutamide Revenue (2021-2032) & (US$ Million) Table 149. Russia Tolbutamide Revenue (2021-2032) & (US$ Million) Table 150. Spain Tolbutamide Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Tolbutamide Revenue (2021-2032) & (US$ Million) Table 152. Switzerland Tolbutamide Revenue (2021-2032) & (US$ Million) Table 153. Sweden Tolbutamide Revenue (2021-2032) & (US$ Million) Table 154. Poland Tolbutamide Revenue (2021-2032) & (US$ Million) Table 155. China Tolbutamide Revenue by Type (2021-2026) & (US$ Million) Table 156. China Tolbutamide Revenue by Type (2027-2032) & (US$ Million) Table 157. China Tolbutamide Sales by Type (2021-2026) & (kg) Table 158. China Tolbutamide Sales by Type (2027-2032) & (kg) Table 159. China Tolbutamide Sales Price by Type (2021-2026) & (US$/kg) Table 160. China Tolbutamide Sales Price by Type (2027-2032) & (US$/kg) Table 161. China Tolbutamide Revenue by Application (2021-2026) & (US$ Million) Table 162. China Tolbutamide Revenue by Application (2027-2032) & (US$ Million) Table 163. China Tolbutamide Sales by Application (2021-2026) & (kg) Table 164. China Tolbutamide Sales by Application (2027-2032) & (kg) Table 165. China Tolbutamide Sales Price by Application (2021-2026) & (US$/kg) Table 166. China Tolbutamide Sales Price by Application (2027-2032) & (US$/kg) Table 167. Asia Tolbutamide Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Tolbutamide Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Tolbutamide Sales by Type (2021-2026) & (kg) Table 170. Asia Tolbutamide Sales by Type (2027-2032) & (kg) Table 171. Asia Tolbutamide Sales Price by Type (2021-2026) & (US$/kg) Table 172. Asia Tolbutamide Sales Price by Type (2027-2032) & (US$/kg) Table 173. Asia Tolbutamide Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Tolbutamide Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Tolbutamide Sales by Application (2021-2026) & (kg) Table 176. Asia Tolbutamide Sales by Application (2027-2032) & (kg) Table 177. Asia Tolbutamide Sales Price by Application (2021-2026) & (US$/kg) Table 178. Asia Tolbutamide Sales Price by Application (2027-2032) & (US$/kg) Table 179. Asia Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Tolbutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Tolbutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Tolbutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 183. Asia Tolbutamide Sales by Country (2021-2026) & (kg) Table 184. Asia Tolbutamide Sales by Country (2027-2032) & (kg) Table 185. Asia Tolbutamide Sales Price by Country (2021-2026) & (US$/kg) Table 186. Asia Tolbutamide Sales Price by Country (2027-2032) & (US$/kg) Table 187. Japan Tolbutamide Revenue (2021-2032) & (US$ Million) Table 188. South Korea Tolbutamide Revenue (2021-2032) & (US$ Million) Table 189. India Tolbutamide Revenue (2021-2032) & (US$ Million) Table 190. Australia Tolbutamide Revenue (2021-2032) & (US$ Million) Table 191. Taiwan Tolbutamide Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Tolbutamide Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Tolbutamide Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Tolbutamide Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Tolbutamide Sales by Type (2021-2026) & (kg) Table 196. SAMEA Tolbutamide Sales by Type (2027-2032) & (kg) Table 197. SAMEA Tolbutamide Sales Price by Type (2021-2026) & (US$/kg) Table 198. SAMEA Tolbutamide Sales Price by Type (2027-2032) & (US$/kg) Table 199. SAMEA Tolbutamide Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Tolbutamide Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Tolbutamide Sales by Application (2021-2026) & (kg) Table 202. SAMEA Tolbutamide Sales by Application (2027-2032) & (kg) Table 203. SAMEA Tolbutamide Sales Price by Application (2021-2026) & (US$/kg) Table 204. SAMEA Tolbutamide Sales Price by Application (2027-2032) & (US$/kg) Table 205. SAMEA Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Tolbutamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Tolbutamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Tolbutamide Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 209. SAMEA Tolbutamide Sales by Country (2021-2026) & (kg) Table 210. SAMEA Tolbutamide Sales by Country (2027-2032) & (kg) Table 211. SAMEA Tolbutamide Sales Price by Country (2021-2026) & (US$/kg) Table 212. SAMEA Tolbutamide Sales Price by Country (2027-2032) & (US$/kg) Table 213. Brazil Tolbutamide Revenue (2021-2032) & (US$ Million) Table 214. Argentina Tolbutamide Revenue (2021-2032) & (US$ Million) Table 215. Chile Tolbutamide Revenue (2021-2032) & (US$ Million) Table 216. Colombia Tolbutamide Revenue (2021-2032) & (US$ Million) Table 217. Peru Tolbutamide Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Tolbutamide Revenue (2021-2032) & (US$ Million) Table 219. Israel Tolbutamide Revenue (2021-2032) & (US$ Million) Table 220. UAE Tolbutamide Revenue (2021-2032) & (US$ Million) Table 221. Turkey Tolbutamide Revenue (2021-2032) & (US$ Million) Table 222. Iran Tolbutamide Revenue (2021-2032) & (US$ Million) Table 223. Egypt Tolbutamide Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Tolbutamide Distributors List Table 227. Tolbutamide Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Tolbutamide Image Figure 2. Global Tolbutamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tolbutamide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Tolbutamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tolbutamide Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacies Image Figure 9. Online Pharmacies Image Figure 10. Hospital Pharmacies Image Figure 11. Global Tolbutamide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Tolbutamide Revenue (2021-2032) & (US$ Million) Figure 13. Global Tolbutamide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Tolbutamide Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Tolbutamide Revenue Market Share by Region (2021-2032) Figure 16. Global Tolbutamide Sales (2021-2032) & (kg) Figure 17. Global Tolbutamide Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 18. Global Tolbutamide Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Tolbutamide Sales YoY (2021-2032) & (kg) Figure 20. Europe Tolbutamide Sales YoY (2021-2032) & (kg) Figure 21. China Tolbutamide Sales YoY (2021-2032) & (kg) Figure 22. Asia (Excluding China) Tolbutamide Sales YoY (2021-2032) & (kg) Figure 23. South America, Middle East and Africa Tolbutamide Sales YoY (2021-2032) & (kg) Figure 24. Global Tolbutamide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Tolbutamide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Tolbutamide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Tolbutamide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Tolbutamide Revenue Market Share by Type (2021-2032) Figure 30. Global Tolbutamide Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 31. Global Tolbutamide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Tolbutamide Sales Market Share by Type (2021-2032) Figure 33. Global Tolbutamide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Tolbutamide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Tolbutamide Revenue Market Share by Application (2021-2032) Figure 36. Global Tolbutamide Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 37. Global Tolbutamide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Tolbutamide Sales Market Share by Application (2021-2032) Figure 39. North America Tolbutamide Revenue Share by Type (2021-2032) Figure 40. North America Tolbutamide Sales Share by Type (2021-2032) Figure 41. North America Tolbutamide Revenue Share by Application (2021-2032) Figure 42. North America Tolbutamide Sales Share by Application (2021-2032) Figure 43. North America Tolbutamide Revenue Share by Country (2021-2032) Figure 44. North America Tolbutamide Sales Share by Country (2021-2032) Figure 45. Europe Tolbutamide Revenue Share by Type (2021-2032) Figure 46. Europe Tolbutamide Sales Share by Type (2021-2032) Figure 47. Europe Tolbutamide Revenue Share by Application (2021-2032) Figure 48. Europe Tolbutamide Sales Share by Application (2021-2032) Figure 49. Europe Tolbutamide Revenue Share by Country (2021-2032) Figure 50. Europe Tolbutamide Sales Share by Country (2021-2032) Figure 51. China Tolbutamide Revenue Share by Type (2021-2032) Figure 52. China Tolbutamide Sales Share by Type (2021-2032) Figure 53. China Tolbutamide Revenue Share by Application (2021-2032) Figure 54. China Tolbutamide Sales Share by Application (2021-2032) Figure 55. Asia Tolbutamide Revenue Share by Type (2021-2032) Figure 56. Asia Tolbutamide Sales Share by Type (2021-2032) Figure 57. Asia Tolbutamide Revenue Share by Application (2021-2032) Figure 58. Asia Tolbutamide Sales Share by Application (2021-2032) Figure 59. Asia Tolbutamide Revenue Share by Country (2021-2032) Figure 60. Asia Tolbutamide Sales Share by Country (2021-2032) Figure 61. SAMEA Tolbutamide Revenue Share by Type (2021-2032) Figure 62. SAMEA Tolbutamide Sales Share by Type (2021-2032) Figure 63. SAMEA Tolbutamide Revenue Share by Application (2021-2032) Figure 64. SAMEA Tolbutamide Sales Share by Application (2021-2032) Figure 65. SAMEA Tolbutamide Revenue Share by Country (2021-2032) Figure 66. SAMEA Tolbutamide Sales Share by Country (2021-2032) Figure 67. Tolbutamide Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Tolbutamide Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • SINE
  • Mylan
  • Changjiang Pharma
  • Pengyao Pharma
  • EASHU Pharma
  • Changzhou Pharma
  • Vexxa LifeScience
  • Sovereign
  • Genesis Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tolbutamide Market by Type
  3. 1.2.1 Global Tolbutamide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Tolbutamide Market by Application
  7. 1.3.1 Global Tolbutamide Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacies
  9. 1.3.3 Online Pharmacies
  10. 1.3.4 Hospital Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Tolbutamide Market Dynamics
  1. 2.1 Tolbutamide Industry Trends
  2. 2.2 Tolbutamide Industry Drivers
  3. 2.3 Tolbutamide Industry Opportunities and Challenges
  4. 2.4 Tolbutamide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tolbutamide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tolbutamide Revenue by Region
  3. 3.2.1 Global Tolbutamide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tolbutamide Revenue by Region (2021-2026)
  5. 3.2.3 Global Tolbutamide Revenue by Region (2027-2032)
  6. 3.2.4 Global Tolbutamide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tolbutamide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tolbutamide Sales by Region
  9. 3.4.1 Global Tolbutamide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tolbutamide Sales by Region (2021-2026)
  11. 3.4.3 Global Tolbutamide Sales by Region (2027-2032)
  12. 3.4.4 Global Tolbutamide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tolbutamide Revenue by Manufacturers
  2. 4.1.1 Global Tolbutamide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tolbutamide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tolbutamide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tolbutamide Sales by Manufacturers
  6. 4.2.1 Global Tolbutamide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tolbutamide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tolbutamide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tolbutamide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tolbutamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tolbutamide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tolbutamide Manufacturers, Product Type & Application
  13. 4.7 Global Tolbutamide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tolbutamide Market CR5 and HHI
  16. 4.8.2 2025 Tolbutamide Tier 1, Tier 2, and Tier 3
5 Tolbutamide Market by Type
  1. 5.1 Global Tolbutamide Revenue by Type
  2. 5.1.1 Global Tolbutamide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tolbutamide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tolbutamide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tolbutamide Sales by Type
  6. 5.2.1 Global Tolbutamide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tolbutamide Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Tolbutamide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tolbutamide Price by Type
6 Tolbutamide Market by Application
  1. 6.1 Global Tolbutamide Revenue by Application
  2. 6.1.1 Global Tolbutamide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tolbutamide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tolbutamide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tolbutamide Sales by Application
  6. 6.2.1 Global Tolbutamide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tolbutamide Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Tolbutamide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tolbutamide Price by Application
7 Company Profiles
  1. 7.1 SINE
  2. 7.1.1 SINE Company Information
  3. 7.1.2 SINE Business Overview
  4. 7.1.3 SINE Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 SINE Tolbutamide Product Portfolio
  6. 7.1.5 SINE Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Tolbutamide Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 Changjiang Pharma
  14. 7.3.1 Changjiang Pharma Company Information
  15. 7.3.2 Changjiang Pharma Business Overview
  16. 7.3.3 Changjiang Pharma Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Changjiang Pharma Tolbutamide Product Portfolio
  18. 7.3.5 Changjiang Pharma Recent Developments
  19. 7.4 Pengyao Pharma
  20. 7.4.1 Pengyao Pharma Company Information
  21. 7.4.2 Pengyao Pharma Business Overview
  22. 7.4.3 Pengyao Pharma Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pengyao Pharma Tolbutamide Product Portfolio
  24. 7.4.5 Pengyao Pharma Recent Developments
  25. 7.5 EASHU Pharma
  26. 7.5.1 EASHU Pharma Company Information
  27. 7.5.2 EASHU Pharma Business Overview
  28. 7.5.3 EASHU Pharma Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 EASHU Pharma Tolbutamide Product Portfolio
  30. 7.5.5 EASHU Pharma Recent Developments
  31. 7.6 Changzhou Pharma
  32. 7.6.1 Changzhou Pharma Company Information
  33. 7.6.2 Changzhou Pharma Business Overview
  34. 7.6.3 Changzhou Pharma Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Changzhou Pharma Tolbutamide Product Portfolio
  36. 7.6.5 Changzhou Pharma Recent Developments
  37. 7.7 Vexxa LifeScience
  38. 7.7.1 Vexxa LifeScience Company Information
  39. 7.7.2 Vexxa LifeScience Business Overview
  40. 7.7.3 Vexxa LifeScience Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vexxa LifeScience Tolbutamide Product Portfolio
  42. 7.7.5 Vexxa LifeScience Recent Developments
  43. 7.8 Sovereign
  44. 7.8.1 Sovereign Company Information
  45. 7.8.2 Sovereign Business Overview
  46. 7.8.3 Sovereign Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sovereign Tolbutamide Product Portfolio
  48. 7.8.5 Sovereign Recent Developments
  49. 7.9 Genesis Pharma
  50. 7.9.1 Genesis Pharma Company Information
  51. 7.9.2 Genesis Pharma Business Overview
  52. 7.9.3 Genesis Pharma Tolbutamide Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Genesis Pharma Tolbutamide Product Portfolio
  54. 7.9.5 Genesis Pharma Recent Developments
8 North America
  1. 8.1 North America Tolbutamide Market Size by Type
  2. 8.1.1 North America Tolbutamide Revenue by Type (2021-2032)
  3. 8.1.2 North America Tolbutamide Sales by Type (2021-2032)
  4. 8.1.3 North America Tolbutamide Price by Type (2021-2032)
  5. 8.2 North America Tolbutamide Market Size by Application
  6. 8.2.1 North America Tolbutamide Revenue by Application (2021-2032)
  7. 8.2.2 North America Tolbutamide Sales by Application (2021-2032)
  8. 8.2.3 North America Tolbutamide Price by Application (2021-2032)
  9. 8.3 North America Tolbutamide Market Size by Country
  10. 8.3.1 North America Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tolbutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tolbutamide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tolbutamide Market Size by Type
  2. 9.1.1 Europe Tolbutamide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tolbutamide Sales by Type (2021-2032)
  4. 9.1.3 Europe Tolbutamide Price by Type (2021-2032)
  5. 9.2 Europe Tolbutamide Market Size by Application
  6. 9.2.1 Europe Tolbutamide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tolbutamide Sales by Application (2021-2032)
  8. 9.2.3 Europe Tolbutamide Price by Application (2021-2032)
  9. 9.3 Europe Tolbutamide Market Size by Country
  10. 9.3.1 Europe Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tolbutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tolbutamide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tolbutamide Market Size by Type
  2. 10.1.1 China Tolbutamide Revenue by Type (2021-2032)
  3. 10.1.2 China Tolbutamide Sales by Type (2021-2032)
  4. 10.1.3 China Tolbutamide Price by Type (2021-2032)
  5. 10.2 China Tolbutamide Market Size by Application
  6. 10.2.1 China Tolbutamide Revenue by Application (2021-2032)
  7. 10.2.2 China Tolbutamide Sales by Application (2021-2032)
  8. 10.2.3 China Tolbutamide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tolbutamide Market Size by Type
  2. 11.1.1 Asia Tolbutamide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tolbutamide Sales by Type (2021-2032)
  4. 11.1.3 Asia Tolbutamide Price by Type (2021-2032)
  5. 11.2 Asia Tolbutamide Market Size by Application
  6. 11.2.1 Asia Tolbutamide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tolbutamide Sales by Application (2021-2032)
  8. 11.2.3 Asia Tolbutamide Price by Application (2021-2032)
  9. 11.3 Asia Tolbutamide Market Size by Country
  10. 11.3.1 Asia Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tolbutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tolbutamide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tolbutamide Market Size by Type
  2. 12.1.1 SAMEA Tolbutamide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tolbutamide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tolbutamide Price by Type (2021-2032)
  5. 12.2 SAMEA Tolbutamide Market Size by Application
  6. 12.2.1 SAMEA Tolbutamide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tolbutamide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tolbutamide Price by Application (2021-2032)
  9. 12.3 SAMEA Tolbutamide Market Size by Country
  10. 12.3.1 SAMEA Tolbutamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tolbutamide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tolbutamide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tolbutamide Value Chain Analysis
  2. 13.1.1 Tolbutamide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tolbutamide Production Mode & Process
  6. 13.2 Tolbutamide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tolbutamide Distributors
  9. 13.2.3 Tolbutamide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst